1991
DOI: 10.1016/0006-8993(91)91161-s
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of U-50,488H analogs for neuroprotective activity in the gerbil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

1992
1992
2009
2009

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(16 citation statements)
references
References 17 publications
0
16
0
Order By: Relevance
“…Ensuring that the volume of tissue being analyzed does not vary between groups can minimize the impact of these variables. This is easily accomplished using Cavalieri’s method which integrates area measurements from systematically random sampled reference sections throughout a 3-dimensional structure (Contreras, Ragan et al, 1991; Mayhew and Olsen, 1991; Costa, Mandarim-de-Lacerda et al, 1991). Should tissue volume vary between experimental groups, then microglia/macrophage cell counts or area measurements can be normalized to their respective reference volumes.…”
Section: Discussionmentioning
confidence: 99%
“…Ensuring that the volume of tissue being analyzed does not vary between groups can minimize the impact of these variables. This is easily accomplished using Cavalieri’s method which integrates area measurements from systematically random sampled reference sections throughout a 3-dimensional structure (Contreras, Ragan et al, 1991; Mayhew and Olsen, 1991; Costa, Mandarim-de-Lacerda et al, 1991). Should tissue volume vary between experimental groups, then microglia/macrophage cell counts or area measurements can be normalized to their respective reference volumes.…”
Section: Discussionmentioning
confidence: 99%
“…However, this may not necessarily be the case. These reports describe neuroprotection by sigma ligands in various in vivo models of neurodegeneration (Long et al, 1990;Contreras et al, 1991;Pontecorvo et al, 1991). In those studies, sigma compounds were administered in vivo and are likely to be present at the site of action in much lower concentrations than those used here.…”
Section: Discussionmentioning
confidence: 99%
“…Receptors are also implicated in the neurodegenerative processes involved in some diseases and some selective 1 -receptor ligands have demonstrated neuroprotective activity. 219,220,230,[232][233][234][235] Very recently, in our own laboratories, the aminoalkylpyridine (AAP) compounds (55, Fig. 20), have been found to act as potent, orally active anticonvulsant agents in the MES model, with long duration of action and no apparent signs of motor toxicity.…”
Section: 231mentioning
confidence: 99%